Risk Factors Associated With Thrombocytopenia Induced by Intravenous Immunoglobulin Formulations: An Analysis Using the JADER database
This study suggests that IVIg can induce thrombocytopenia and that thrombocytopenia should be assessed in patients with immune-mediated skin diseases, immune-mediated muscular diseases and in the elderly.
Authors
- Natsuko Ishida (ORCID: https://orcid.org/0000-0002-3011-3714)
- Hirotaka Nagai (ORCID: https://orcid.org/0000-0003-0983-8670)
- Junko Ishizaki (ORCID: https://orcid.org/0000-0002-5002-3513)
- Togen Masauji (ORCID: https://orcid.org/0009-0000-5897-8800)
- Yoshihiro Nishita (ORCID: https://orcid.org/0000-0002-5035-4443)
Institutions
- Kanazawa University Hospital (JP)
- Kanazawa Medical University Hospital (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.14028
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00